Inventor · disambiguated record
Ibrahim John Malik
Also filed as: MALIK IBRAHIM JOHN
17 granted patents·3 pending applications·118 citations·filing 2016–2022
95Inventor score
Files withH LUNDBECK AS20
Top patents by PatentIndex Score
20 records- 0198US11542323B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2020·Granted Jan 3, 2023·6 cites·24 claims
- 0298US11524995B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2020·Granted Dec 13, 2022·6 cites·20 claims
- 0397US11421024B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2020·Granted Aug 23, 2022·6 cites·23 claims
- 0497US10800836B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2016·Granted Oct 13, 2020·10 cites·10 claims
- 0597US10647764B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2019·Granted May 12, 2020·9 cites·14 claims
- 0697US10647763B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2019·Granted May 12, 2020·9 cites·14 claims
- 0797US10640554B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2019·Granted May 5, 2020·9 cites·14 claims
- 0896US10364285B2Antibodies for the treatment of synucleinopathyH LUNDBECK AS·Filed 2017·Granted Jul 30, 2019·13 cites·9 claims
- 0996US10358484B2Antibodies for the treatment of synucleinopathyH LUNDBECK AS·Filed 2017·Granted Jul 23, 2019·13 cites·9 claims
- 1096US10358483B2Antibodies for the treatment of synucleinopathyH LUNDBECK AS·Filed 2017·Granted Jul 23, 2019·13 cites·9 claims
- 1195US10358482B2Antibodies for the treatment of synucleinopathyH LUNDBECK AS·Filed 2017·Granted Jul 23, 2019·11 cites·9 claims
- 1292US10479835B2Agent, uses and methods for treatmentH LUNDBECK AS·Filed 2016·Granted Nov 19, 2019·4 cites·16 claims
- 1392US10428147B2Anti-sortilin antibodies, uses and methods for treatmentH LUNDBECK AS·Filed 2016·Granted Oct 1, 2019·4 cites·7 claims
- 1490US10889650B2Agent, uses and methods for treatmentH LUNDBECK AS·Filed 2019·Granted Jan 12, 2021·2 cites·19 claims
- 1588US11548950B2Agent, uses and methods for treatmentH LUNDBECK AS·Filed 2020·Granted Jan 10, 2023·1 cites·19 claims
- 1685US2023312693A1Agents, Uses and Methods for the Treatment of SynucleinopathyH LUNDBECK AS·Filed 2022·Application pending·0 cites
- 1784US12331123B2Agent, uses and methods for treatmentH LUNDBECK AS·Filed 2022·Granted Jun 17, 2025·0 cites·22 claims
- 1882US10894833B2Agents, uses and methods for treatmentH LUNDBECK AS·Filed 2018·Granted Jan 19, 2021·2 cites·4 claims
- 1960US2021292414A1Agents, uses and methods for treatmentH LUNDBECK AS·Filed 2020·Application pending·0 cites
- 2048US2020309796A1Assay, method and treatment of alpha-synucleinopathiesH LUNDBECK AS·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ibrahim John Malik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →